Past Events

The 17th annual BIO-Europe® event will be the largest biotechnology partnering conference held in Europe. Close to 3,000 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. BIO-Europe features the industry's most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. Intended for: Top international executives from: Established and emerging biotech companies Pharmaceutical companies Institutional financial firms Private investors including venture capital and private equity firms

This course is designed to provide essential training for conducting Out of Specification (OOS) investigations in a GMP environment. A background discussion of the associated GMP documentation required to support the OOS investigation is included but the majority of time is spent detailing the who, what, when, how and why of the investigation, determining the extent of the investigation during Phase I and Phase II, documenting findings determining root causes and assigning corrective and preventative actions. This course is presented in a dynamic environment created by a power point presentation, interactive exercises, case studies and group discussion. Participants are welcome to bring their own examples for group discussion sessions. The workshop emphasizes practical issues such as: • The importance of good quality support systems • FDA audit observations and how they could have been avoided • Case studies • A detailed guide to conducting Phase 1 and Phase II of the investigation • Reporting and evaluating passing and failing results The course provides ample opportunities for group discussions, case studies and exercises. It enables participants to gain the skills and knowledge necessary to meet current regulatory expectations. The course material is based on the FDA guideline “Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production”, October 2006

The conference trends: • Astrobiology • Prebiotic Evolution • The Emergence of Cells • Living Conditions in the Early Earth. Early Biosphere • Early Eukaryotes • Evolution of the Geo-Biological Systems in Phanerozoic

This course provides helpful information by presenting topics associated with the writing, formatting, execution, management and global harmonization of SOP’s. It also discusses good documentation practices required by companies to ensure GMP compliance and relates the role which SOP’s play in achieving the required level of compliance and quality. The course material is presented by means of slides, handouts and participation of the attendees through discussion and individual/group exercises. Note: Participants may bring an SOP related to their work for the workshop exercise on day two. The workshop emphasises practical issues such as: • The benefits of SOP’s • The logical approach to defining and writing the procedure section of the SOP • Writing SOP’s as part of a team • Critiquing an example of a badly written SOP The course provides ample opportunities for group discussions and hands on exercises. It enables participants to gain the skills and knowledge necessary to meet the expectations of regulatory agencies.

This unique 3 day course is designed to integrate the key elements of tablet development with hands-on, practical experience in a small scale, lab scale test facility. Each day will consist of lectures on aspects of tablet development, followed by linked sessions in which participants take part in related experimental work. The course enables attendees to apply the theory learnt in the taught sessions, and also to directly observe the effect of formulation on product properties, and relate the theory to the practice of Quality by Design (QbD). Who Should Attend? • Newcomers to tablet formulation development and manufacturing • Production operators who need a better understanding of their products and how they have been developed • Analytical and QC staff who would benefit from understanding the tablet development and production process • Experienced personnel in one area of product development who need a broader overview • Project team members needing a broader insight into formulation development including preclinical, clinical, and project management representatives • Regulatory staff who would benefit from brief practical experience of the processes for which they are compiling dossiers. Regulatory agency staff requiring practical experience Numbers are restricted to 10 participants for maximum benefit Learning outcomes • Understanding of the relationship between Quality by Design, drug substance properties, formulation and process development • Practical experience of small scale tablet manufacture with direct knowledge of the relationship between formulation properties and tablet compressibility • Understanding of the roles of critical quality attributes, critical process parameters, and product control strategy in the application of the principles of QbD to formulation development

Schwerzenbach, Switzerland. 26 January, 2011. METTLER TOLEDO has scheduled the 18th Annual International Process Development Conference (IPDC) for September 25-29, 2011 at the Park Hotel in picturesque Weggis, Switzerland. This year’s conference chair is Fabio Visentin, European Team Leader, Technology & Applications Consultants at METTLER TOLEDO. Focus areas for the 18th Annual IPDC will be Chemical Research & Development, Process Characterization and Crystallization, Process Safety and Scale-up and Manufacturing. Special emphasis will be on Process Analytical Technology/Quality by Design (PAT/QbD), continuous processing & flow chemistry, and kinetics. Papers on chemical or process R&D, Process Analytical Technology (PAT), crystallization, process safety, online analytics and related areas are currently being accepted for presentation at the conference. The IPDC provides a forum for sharing the latest in process development covering the entire workflow from initial early phase development and screening to scale-up and manufacturing in pharmaceuticals, as well as the fine and specialty chemical industries. It draws a variety of industry experts, including: · organic chemists working in synthesis or development · process & development chemists focused on process characterization, troubleshooting or material production in the kilo scale · chemical engineers in process development, crystallization, safety and scale-up · department managers charged with chemical development productivity, and · R&D project team leaders. Specialists from both industry and academia will share trends in chemical research and development; process characterization and crystallization; process safety and scale-up, and production. Additionally, METTLER TOLEDO consultants and industry professionals will discuss leading-edge technology including personal synthesis workstations, reaction calorimetry, mid-IR/particle characterization, and how data gathered using these methods can improve results and help lower costs.

ARROWHEAD’S ANNUAL PAIN THERAPEUTICS SUMMIT is the US’s premier conference covering the field of pain management and therapeutics. Leaders from the pharmaceutical, biotech, device and medical communities attend this conference to learn about the latest advances in the treatment of various types of pain and to network with colleagues from industry, the non-profit sector, academia, the medical community, government and investors. This conference will provide attendees with thoughtful insight from key industry leaders and academic researchers concerning cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies and newly marketed products. We will highlight the most important developments in recent years in the field, including new research in CGRP antagonists, NGF antagonists, Nav 1.7 antagonists, new research in biologic therapies and the genetic component of pain, abuse-resistant opioids, analysis of FDA’s REMS program and a plethora of other topics.

This advanced application-oriented two-day course in LC-MS pays attention to the important aspects of quantitative bioanalysis by LC-MS, except for statistical aspects in data-processing. Starting from providing knowledge on important processes in analyte ionization by electrospray or APCI, the course provides a profound understanding of the important topics of quantitative bioanalysis using LC-MS. Quality control in instrument performance, method development, and systematic troubleshooting are key issues throughout the course. The theoretical parts of the course are illustrated with a number of case studies. Experience with the LC-MS instrumentation is recommended prior to attending this course The aim is to provide the participants with the general principles, background knowledge, and how to use this knowledge in practice.

This one-day course provides an introduction to technology and (potential) application areas of combined liquid chromatography-mass spectrometry (LC–MS) in small-molecule pharmaceutical industry. The morning sessions provide a clear technology overview, introducing analyte ionization techniques, different types of mass analysers, and important data acquisition strategies. The two afternoon sessions focus on applications in quantitative and qualitative analysis, respectively.

The efficient conversion of a chemical process into a process for manufacture on tonnage scale has always been of key importance in the chemical and pharmaceutical industries. In the current economic and regulatory climate, it has become increasingly vital and challenging to do so efficiently. At this conference, you will hear detailed presentations and case studies from top international chemists. Our hand-picked programme of speakers - put together specifically for an industrial audience – will discuss the latest issues relating to synthetic route design, development and optimisation in the pharmaceutical, fine chemical and allied fields.

BioPharm America™ is where biotech industry partnerships get started. This three-day conference provides a proven and highly productive format for establishing new business relationships. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, the world's leading web-based partnering system for the life science industry, BioPharm America is the only event in North America based on the same reputable formula as EBD Group's acclaimed European events BIO-Europe® and BIO-Europe Spring®. In 2010, BioPharm America attracted 850 delegates from 565 companies who participated in 2,550+ scheduled one-to-one meetings.

This conference will feature international presenters who will provide a forum for the discussion of issues related to the influence of the mixing unit operation in the chemical industry form the synthetic route design, development, Quality by Design (QbD), optimization, Process Analysis Test (PAT), impurities control, scale-up, design, process simulation, process safety and production.

This is the major international forum for the discussion of all technical aspects of scale-up at the chemistry/chemical engineering interface. Topics include: the scale up of batch and semi-batch processes, continuous processing and reaction engineering, microreactor technology, safety and thermochemistry, scale up of potentially hazardous chemistry, green chemistry, quality assurance and regulatory concerns, solid form control (crystallisation and polymorphism), separation and purification techniques, and new technologies and equipment for large scale manufacture.

SCOPE Conducting polymers are studied because of their conductivity, as functional materials, and for their ability to respond to external stimuli. Polyaniline and polypyrrole are typical but by no means the only conducting polymers. They are investigated alone, or as components of compound materials. The synthesis of conducting polymers and the preparation of their composites, their structural characterization, their physical and chemical properties, and their applications both in well-established and new surprising directions are of interest. TOPICS Chemical and electrochemical synthesis of conducting polymers, the control of molecular structure and supramolecular morphology. Preparation of thin films, colloidal particles, and coatings. Composite materials comprising conducting polymers, combinations of conducting polymers with noble metals, carbons, and other inorganic and organic components. Related oligomers. The chemical modification and carbonization of conducting polymers. Processing of conducting polymers and their stability. Characterization of conducting polymers by spectroscopic methods. Modelling and simulations. Molar masses and molecular architecture. Electrical, magnetic, mechanical, optical and other physical properties of conducting polymers. Charge transport. Chemical properties of conducting polymers. The relations between the chemical and physical properties of conducting polymers. Applications of conducting polymers as conducting materials, e.g., in flexible electronics. The use of conducting polymers in corrosion protection, in electrorheology. Conducting polymers in energy conversions, as electrode materials in fuel cells, batteries, and supercapacitors. The design of analytical devices, sensors, and actuators. The role of conducting polymers in catalysis and electrocatalysis, separation science and membrane technologies, in biomedical applications and other fields.

Select Biosciences is delighted to announce the inaugural European Lab Automation congress. The first event will be held in the historic city of Hamburg during the most pleasant season of the year.

The Canadian Light Source 14th Annual Users' Meeting will be held in Saskatoon June 24-25, 2011. This meeting is a great opportunity to learn about the progress of the Canadian Light Source, present your recent synchrotron work and meet fellow users.

The fifth Synchrotron Environmental Science meeting will be held in Saskatoon June 23, 2011. Continuing the tradition established by previous SES conferences, SES V will bring together a diverse community of environmental and synchrotron scientists.

This conference will showcase synthetic chemistry involving hazardous reagents, intermediates and/or reaction conditions carried out at industrial scale. Safety aspects and changes to reaction conditions to avoid dangerous operating conditions will be highlighted.

The Canadian Synchrotron Summer School is for researchers who wish to add synchrotron techniques to their research skill set. Information is presented through lectures, case studies, and practical, hands-on experience on beamlines in collecting and analyzing data.

The 3rd International Symposium on Metallomics will feature a host of sessions, stimulating the interdisciplinary discussion between analytical chemists, biologists, physicians and clinical scientists from industry, government, academia, doctoral and graduate students. The main topics are: * Techniques and methods for metallomics (new instrumentation and technology, metal tags and labels, metal imaging and new methods) * Human Metallomics * BioGeo Metallomics * Phyto Metallomics * Microbial Metallomics * Environmental Metallomics